文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

全外显子组测序确定FANCM是西班牙裔/拉丁裔女性雌激素受体阴性乳腺癌的一个易感基因。

Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women.

作者信息

Nierenberg Jovia L, Adamson Aaron W, Hu Donglei, Huntsman Scott, Patrick Carmina, Li Min, Steele Linda, Tao Shu, Ding Yuan Chun, Tong Barry, Shieh Yiwey, Fejerman Laura, Gruber Stephen B, Haiman Christopher A, John Esther M, Kushi Lawrence H, Torres-Mejía Gabriela, Ricker Charité, Weitzel Jeffrey N, Ziv Elad, Neuhausen Susan L

机构信息

Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA.

Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

出版信息

Nat Commun. 2025 Aug 21;16(1):7816. doi: 10.1038/s41467-025-60564-0.


DOI:10.1038/s41467-025-60564-0
PMID:40841357
Abstract

Breast cancer (BC) is one of the most common cancers globally. Genetic testing facilitates screening and informs targeted risk-reduction and treatments. However, genes included in testing panels are from European-ancestry studies. We conducted a pooled case-control analysis in self-identified Hispanic/Latina women (4178 cases and 4344 controls), using whole exome sequencing and a targeted panel. We tested the association of loss of function (LoF) variants with overall, estrogen receptor (ER)-positive, and ER-negative BC risk. Using logistic regression, we found a strong association of LoF variants in FANCM with ER-negative BC (p = 4.1 × 10), odds ratio [confidence interval]: 6.7 [2.9-15.6]). Among known susceptibility genes, BRCA1, BRCA2, and PALB2 strongly associated with BC. FANCM was previously proposed as a possible susceptibility gene for ER-negative BC, but is not routinely tested clinically. Our results demonstrate that FANCM should be added to BC gene panels.

摘要

乳腺癌(BC)是全球最常见的癌症之一。基因检测有助于筛查,并为针对性的风险降低和治疗提供信息。然而,检测面板中包含的基因来自欧洲血统的研究。我们对自我认定的西班牙裔/拉丁裔女性(4178例病例和4344例对照)进行了一项汇总病例对照分析,使用全外显子测序和一个靶向检测面板。我们测试了功能丧失(LoF)变异与总体、雌激素受体(ER)阳性和ER阴性乳腺癌风险之间的关联。使用逻辑回归,我们发现FANCM基因中的LoF变异与ER阴性乳腺癌有很强的关联(p = 4.1×10,优势比[置信区间]:6.7 [2.9 - 15.6])。在已知的易感基因中,BRCA1、BRCA2和PALB2与乳腺癌密切相关。FANCM此前被提议作为ER阴性乳腺癌的一个可能的易感基因,但临床上并不常规检测。我们的结果表明,FANCM应添加到乳腺癌基因检测面板中。

相似文献

[1]
Whole exome sequencing identifies FANCM as a susceptibility gene for estrogen-receptor-negative breast cancer in Hispanic/Latina women.

Nat Commun. 2025-8-21

[2]
Whole exome sequencing and replication for breast cancer among Hispanic/Latino women identifies as a susceptibility gene for estrogen-receptor-negative breast cancer.

medRxiv. 2023-1-28

[3]
Detection rates of multigene panel and exome testing in patients with previous negative BRCA1/2 results.

Fam Cancer. 2025-5-26

[4]
Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs.

Breast Cancer Res. 2018-1-9

[5]
Economic evaluation of personalised versus conventional risk assessment for women who have undergone testing for hereditary breast and ovarian cancer genes: a modelling study.

J Med Genet. 2025-6-24

[6]
Fanconi Anemia

1993

[7]
FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women.

Eur J Hum Genet. 2023-5

[8]
Reproductive characteristics, menopausal status, race and ethnicity, and risk of breast cancer subtypes defined by ER, PR and HER2 status: the Breast Cancer Etiology in Minorities study.

Breast Cancer Res. 2024-5-31

[9]
Expression- and splicing-based multi-tissue transcriptome-wide association studies identified multiple genes for breast cancer by estrogen-receptor status.

Breast Cancer Res. 2024-3-21

[10]
Increased risk of hypertrophic scarring in estrogen receptor-positive breast cancer: a bidirectional mendelian randomization study.

Arch Dermatol Res. 2025-1-20

本文引用的文献

[1]
Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk.

Nat Genet. 2023-9

[2]
Germline Genetic Testing After Cancer Diagnosis.

JAMA. 2023-7-3

[3]
Breast cancer risks associated with missense variants in breast cancer susceptibility genes.

Genome Med. 2022-5-18

[4]
Genetic epidemiology of BRCA1- and BRCA2-associated cancer across Latin America.

NPJ Breast Cancer. 2021-8-19

[5]
FANCM regulates repair pathway choice at stalled replication forks.

Mol Cell. 2021-6-3

[6]
The ten genes for breast (and ovarian) cancer susceptibility.

Nat Rev Clin Oncol. 2021-5

[7]
A Population-Based Study of Genes Previously Implicated in Breast Cancer.

N Engl J Med. 2021-2-4

[8]
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

J Natl Compr Canc Netw. 2021-1-6

[9]
The :p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

NPJ Breast Cancer. 2019-11-1

[10]
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.

JAMA. 2019-8-20

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索